The CD3+CD4−CD8− double-negative T cells appear to contribute to the pathogenesis and clinical outcome of MHV-3-induced fulminant viral hepatitis via the immunoactivity of FGL2 in a mouse model [29]. Here, FGL2 is linked to fulminant viral hepatitis.